CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

VibroLUNGWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (3)

Name (Synonyms) Correlation
D000860 Hypoxia NIH 0.23
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0012418 Hypoxemia HPO 0.23

There is one clinical trial.

Clinical Trials

1 Assessment of the Effectiveness of Vibroacoustic Therapy for Respiratory Failure Caused by COVID 19

Vibroacoustic pulmonary therapy in patients with COVID19 is believed to have a positive effect on oxygen status and a decrease in the duration of respiratory failure

NCT04435353 Respiratory Distress Syndrome Hypoxemia Device: VibroLUNG
MeSH:Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Respiratory Insufficiency Hypoxia
HPO:Hypoxemia

Primary Outcomes

Description: Regression of respiratory failure under the influence of vibroacoustic therapy

Measure: Recovery respiratory fail

Time: 5-7 days

Related HPO nodes (Using clinical trials)

HP:0012418: Hypoxemia
Genes 14
GATA6 GDNF HBB SLC35A1 ASCL1 ZFPM2 EDN3 HBB RET PHOX2B CSF2RA FBN1 FGFR3 CSF2RB
Protein Mutations 2
P317R R200W
SNP 0